In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CHL leads Vascular Pathways' $14mm Series B

Executive Summary

CHL Medical Partners has led Vascular Pathways Inc.'s (catheters for easy insertion of intravenous therapeutics) $14mm Series B venture round. Ascension Health Ventures, MVM Life Science Partners, and Arcus Ventures also participated. Representatives from CHL, MVM, and Ascension will take seats on the company's board.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies